Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate

NCT04358419 is registered in ClinicalTrials.gov with Inger Lise Gade as lead sponsor.

NCT NCT04358419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04358419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
Lead sponsor
Inger Lise Gade
Phase
Observational
Overall status
Completed
Start date
April 17, 2020
Completion date
December 31, 2023
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspergillosis pneumonia, pneumocystis pneumonia